AYTU
Aytu BioPharma·NASDAQ
--
--(--)
--
--(--)
7.27 / 10
Outperform
Fund-flow analysis is encouraging, with a score of 7.61/10 and overall positive trend. Block, Small, Large, and Extra-large orders show net inflows (ratios 0.52-0.55), while Medium orders are slightly negative (0.47). This indicates institutional and retail interest, supporting the idea that dip-buyers are active. Coupled with a unanimous Strong Buy analyst rating from Ascendiant Capital, the fund-flow data reinforce a bullish sentiment that could help stabilize the stock once technicals improve.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-10
InstitutionAscendiant Capital
Times predicted3
Historical Win Rate100.0%
What is the analyst consensus for AYTU?
- AYTU holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.27/10 (Outperform).
